l-6100 Leptomycin B, Free Acid, >99%

Related Terms : [LMB] [Elactocin] [Mantuamycin] [CI-940] [CL-1957A] [PD-114720] [ATS 1287B]

  • Size
  • US $
  • £
  • ¥
  • 100 µg
  • 89
  • 81
  • 72
  • 9,200
  • Add to Cart Qty:
  • In stock
  • 500 µg
  • 348
  • 319
  • 284
  • 36,100
  • Add to Cart Qty:
  • In stock
  • 1 mg
  • 585
  • 537
  • 478
  • 60,700
  • Add to Cart Qty:
  • In stock

Note: Our Euro, Pound, and Yen prices are revised regularly to account for currency exchange rate fluctuations.

To receive a Quotation for catalog sizes of this product and/or any other products, please add them to your shopping cart and click on the “REQUEST A QUOTATION” box.
Click Here to Request a Quotation for Larger Quantities Click Here to see what Shipping and Handling Costs would be to Your Country
  • M.W. 540.73
  • C33H48O6
  • [87081-35-4]
  • M.I. 14: 5444

Storage: Store tightly sealed at or below -20 ºC. Solubility: Soluble in methanol or ethanol. Disposal: A.

  • More than 1,000 labs worldwide have purchased Leptomycin B from LC Labs (either directly from us or from our many distributors, many of whom resell under their own labels).
  • Leptomycin B (LepB) is a potent, specific inhibitor of nuclear export signal (NES)-dependent protein export from the nucleus. Fukuda. M., et al. "CRM1 is responsible for intracellular transport mediated by the nuclear export signal." Nature 390: 308-311 (1997).
  • The effect of LepB on the CRM1 (exportin 1) NES receptor results from selective alkylation by LepB of a single cysteine residue. Kudo, N., et al. "Leptomycin B inactivates CRM1/exportin 1 by covalent modification at a cysteine residue in the central conserved region." Proc. Natl. Acad. Sci. USA 96: 9112-9117 (1999)
  • LepB inhibits the nucleo-cytoplasmic translocation of the HIV Rev protein at nanomolar concentrations. Wolff, B., et al. "Leptomycin B is an inhibitor of nuclear export: inhibition of nucleo-cytoplasmic translocation of the human immunodeficiency virus type 1 (HIV-1) Rev protein and Rev-dependent mRNA." Chem Biol. 4: 139-147 (1997).
  • LepB also exhibits potent antitumor activity in vitro and in vivo, and possesses potent antimycotic and antibiotic activity. Tunac, J.B., et al. "Novel antitumor antibiotics, CI-940 (PD 114,720) and PD 114,721. Taxonomy, fermentation and biological activity." J. Antibiot. 38: 460-465 (1985).
  • POTENCY: LepB typically exhibits IC50 values in the 1 nM range, depending on the species, cell type, and phenomenon under study.
  • Our LepB is supplied in serum bottles with teflon-lined closures containing a solution in absolute ethanol (a better solvent than methanol/water; see "Solvent" below).
    • The 100 µg size is supplied as 185 µL of a 1 mM solution (540 µg/mL).
    • The 500 µg size is supplied as 925 µL of a 1 mM solution.
    • The 1 mg size is supplied as 1.85 mL of a 1 mM solution.
    • Larger quantities and higher concentrations are available - please request a quotation.
    • SOLVENT: WARNING -- LEPTOMYCIN B IS UNSTABLE IN DMSO. DO NOT USE ANY DMSO WITH LEPTOMYCIN B. Ethanol is a better solvent for LepB than methanol for at least three reasons. First, published information indicates that LepB is more stable in ethanol (purity unchanged after 5 months at room temperature: US patent 4,771,070) than in methanol/water 70/30 (freezer temperatures required for storage for more than a few days: Sigma newsletter LifeScience 2, April 2001, page 11). Second, ethanol has a significantly higher boiling point than methanol, so ethanol solutions are expected to be less susceptible to changes in concentration due to solvent evaporation. Third, LepB is a relatively hydrophobic compound, and may have a tendency to stick to plastic. Being a much stronger organic solvent than methanol/water, ethanol reduces the potential loss of LepB when handled in plastic.
    • DILUTING LepB SOLUTIONS: Dilutions of LepB for dose response studies should be made in an organic solvent, preferably ethanol, with only the final dilution being made into culture medium.
    • STABILITY WARNING: LepB in any quantity is unstable when dried down into a film. Thus, under no circumstances should the solvent be removed from solutions of LepB, because rapid decomposition and loss of recoverable material will result.
    • We note that, as of August 2010, at least three suppliers, namely Selleck Chemicals LLC, Biotrend, now sell leptomycin B in a dried-down, solvent-free form. From our experience it is highly likely that the solid form will provide far less than the amounts of leptomycin B claimed on these vendors' vial labels. The original report describing leptomycin B stated quite clearly that leptomycin B is unstable as a solid and cannot be dried down and then successfully used at its expected potency. For example, we tested a sample of dried-down leptomycin B from a different vendor by treating it with methanol, an excellent leptomycin B solvent, and then doing an HPLC assay. The result was a nice, clean-looking peak that showed high purity. HOWEVER, THIS IS VERY MISLEADING -- IT WAS A NICE CLEAN PEAK, BUT WHEN CAREFULLY QUANTITATED, IT CONTAINED LESS THAN 40% OF THE EXPECTED AMOUNT OF LEPTOMYCIN B. This indicates that drying leptomycin B down to a solid probably results in partial polymerization to a highly insoluble material that cannot be redissolved. So, we predict that use of leptomycin B in dried-solid form from any source will result in large amounts of wasted time and money.
    • STABILITY TESTING: To test LepB stability in ethanol, we tested LepB dilutions under two different temperature conditions. One set of samples was maintained at freezer temperatures after purification and dilution, and then sent in ice to an academic laboratory in Texas. A second set of samples was heated in an oven to 60 ºC for two hours, then shipped to the same Texas lab, in the middle of August, without ice or refrigeration, and the samples were assayed for inhibition of COS cell growth. No significant differences were found between the two temperature conditions. In another test, we refluxed a sample of our LepB in ethanol (b.p. 78.5 ºC) for an hour; at the end of this period, HPLC analysis showed that decomposition products amounted to less than 1%.
    • SHIPPING CONDITIONS: We ship our LepB product at ambient temperature, without ice. All the information we have indicates that LepB is stable for at least many days, if not months, under ambient conditions. Thus, the extra cost of ice shipments does not appear to be justified. However, for maximum long-term stability, LepB solutions should be stored at -20 ºC or colder.
    • Sold for laboratory or manufacturing purposes only; not for human, medical, veterinary, food, or household use.